Arterys, the leader in intelligent, cloud-based medical image analysis software, today announced that it has been named for the second consecutive year to CB Insights’ coveted AI 100 ranking, which showcases the 100 most promising private artificial intelligence (AI) companies in the world.
| SAN FRANCISCO, /PRNewswire/ -- Arterys, the leader in intelligent, cloud-based medical image analysis software, today announced that it has been named for the second consecutive year to CB Insights’ coveted AI 100 ranking, which showcases the 100 most promising private artificial intelligence (AI) companies in the world. Arterys was recognized for its cloud-based AI medical imaging platform, which enhances and expedites physicians’ ability to interpret clinical images for accurate diagnosis.
“We are honored to again be recognized in the AI 100. This award validates the innovative work the Arterys team is passionately doing,” said Arterys CEO Fabien Beckers. “Our ability to fuse AI technology with a suite of cloud-based solutions enables us to address one of the toughest challenges in modern medicine: efficient interpretation of exponentially growing volumes of images and data. We thank CB Insights for showcasing Arterys’ leadership in healthcare AI as we continue to advance this technology for physicians and their patients.” Arterys has introduced the world’s first true medical imaging cloud platform that is powered by artificial intelligence, 100 percent web-based, and cleared by the U.S. Food and Drug Administration (FDA). Arterys leverages deep learning, the power of cloud computing, and convenience of internet accessibility with a suite of advanced imaging applications that enhance clinician workflow, reduce subjectivity and improve diagnostic accuracy. Through an evidence-based approach, the CB Insights research team selected the AI 100 from over 3,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum. “After being named to the AI 100 in 2018, last year’s honorees raised nearly $4.5B across 45 deals with 6 going on to be valued at $1 billion or more,” said CB Insights CEO Anand Sanwal. “The data we compiled on this year’s nominees, ranging from their customers to their patients to their CB Insights Mosaic scores, revealed 100 AI companies that are driving transformation across a number of industries and which are taking on a variety of large societal issues ranging from disaster management to cancer diagnosis to detecting fake news. We expect these companies will see similar levels of momentum and progress in 2019 and are excited to continue to track their progress.” About Arterys, Inc. The company’s goal is to reduce variability and subjectivity in clinical diagnoses, and alleviate the enormous workloads radiologists face. With AI, the company is improving the accuracy and consistency in imaging interpretation across practices. Arterys is now leveraging its medical imaging platform to expanding its technology beyond Cardiac MR to create other imaging applications to make medical imaging services vastly more automated, quantitative and useful. Follow Arterys on Twitter @ArterysInc and LinkedIn https://www.linkedin.com/company/arterys/ Contact: info@arterys.com About CB Insights
SOURCE Arterys, Inc. |
View original content to download multimedia:
